Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 5
2004 5
2005 9
2006 7
2007 12
2008 15
2009 9
2010 12
2011 6
2012 5
2013 6
2014 7
2015 6
2016 5
2017 4
2018 9
2019 6
2020 5
2021 2
2022 3
2023 15
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing.
Cikes D, Elsayad K, Sezgin E, Koitai E, Torma F, Orthofer M, Yarwood R, Heinz LX, Sedlyarov V, Miranda ND, Taylor A, Grapentine S, Al-Murshedi F, Abot A, Weidinger A, Kutchukian C, Sanchez C, Cronin SJF, Novatchkova M, Kavirayani A, Schuetz T, Haubner B, Haas L, Hagelkruys A, Jackowski S, Kozlov AV, Jacquemond V, Knauf C, Superti-Furga G, Rullman E, Gustafsson T, McDermot J, Lowe M, Radak Z, Chamberlain JS, Bakovic M, Banka S, Penninger JM. Cikes D, et al. Among authors: chamberlain js. Nat Metab. 2023 Mar;5(3):495-515. doi: 10.1038/s42255-023-00766-2. Epub 2023 Mar 20. Nat Metab. 2023. PMID: 36941451
Viral vector-mediated gene therapies.
Hollinger K, Chamberlain JS. Hollinger K, et al. Among authors: chamberlain js. Curr Opin Neurol. 2015 Oct;28(5):522-7. doi: 10.1097/WCO.0000000000000241. Curr Opin Neurol. 2015. PMID: 26263476 Free PMC article. Review.
AAV-based gene therapies for the muscular dystrophies.
Crudele JM, Chamberlain JS. Crudele JM, et al. Among authors: chamberlain js. Hum Mol Genet. 2019 Oct 1;28(R1):R102-R107. doi: 10.1093/hmg/ddz128. Hum Mol Genet. 2019. PMID: 31238336 Free PMC article. Review.
Clinical potential of microdystrophin as a surrogate endpoint.
Boehler JF, Brown KJ, Beatka M, Gonzalez JP, Donisa Dreghici R, Soustek-Kramer M, McGonigle S, Ganot A, Palmer T, Lowie C, Chamberlain JS, Lawlor MW, Morris CA. Boehler JF, et al. Among authors: chamberlain js. Neuromuscul Disord. 2023 Jan;33(1):40-49. doi: 10.1016/j.nmd.2022.12.007. Epub 2022 Dec 14. Neuromuscul Disord. 2023. PMID: 36575103 Free article. Review.
Progress toward Gene Therapy for Duchenne Muscular Dystrophy.
Chamberlain JR, Chamberlain JS. Chamberlain JR, et al. Among authors: chamberlain js. Mol Ther. 2017 May 3;25(5):1125-1131. doi: 10.1016/j.ymthe.2017.02.019. Epub 2017 Apr 15. Mol Ther. 2017. PMID: 28416280 Free PMC article. Review.
A Boost for Muscle with Gene Therapy.
Chamberlain JS. Chamberlain JS. N Engl J Med. 2022 Mar 24;386(12):1184-1186. doi: 10.1056/NEJMcibr2118576. N Engl J Med. 2022. PMID: 35320650 No abstract available.
Animal models of muscular dystrophy.
Ng R, Banks GB, Hall JK, Muir LA, Ramos JN, Wicki J, Odom GL, Konieczny P, Seto J, Chamberlain JR, Chamberlain JS. Ng R, et al. Among authors: chamberlain js. Prog Mol Biol Transl Sci. 2012;105:83-111. doi: 10.1016/B978-0-12-394596-9.00004-4. Prog Mol Biol Transl Sci. 2012. PMID: 22137430 Free PMC article. Review.
In vivo selection of synthetic nucleocapsids for tissue targeting.
Olshefsky A, Benasutti H, Sylvestre M, Butterfield GL, Rocklin GJ, Richardson C, Hicks DR, Lajoie MJ, Song K, Leaf E, Treichel C, Decarreau J, Ke S, Kher G, Carter L, Chamberlain JS, Baker D, King NP, Pun SH. Olshefsky A, et al. Among authors: chamberlain js. Proc Natl Acad Sci U S A. 2023 Nov 14;120(46):e2306129120. doi: 10.1073/pnas.2306129120. Epub 2023 Nov 8. Proc Natl Acad Sci U S A. 2023. PMID: 37939083 Free PMC article.
156 results